Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lesko

Showing results (161-170 of 231) with videos related to

Pageof 24
Sort By:
Pharmacogenomics|July 21, 2021
Tabula Rasa HealthCare company profile: involvement in pharmacogenomic and personalized medicine researchAdriana Matos, Pamela Dow, Jennifer M Bingham, et al.
Clinical and Translational Science|February 22, 2022
Application of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitorsSarah Kim, Gezim Lahu, Majid Vakilynejad, et al.
Journal of Clinical Pharmacology|February 5, 2019
Is Bioequivalence Established Based on the Reference-Scaled Average Bioequivalence Approach Relevant to Chronic Administration of Phenytoin? Perspectives Based on Population Pharmacokinetic Modeling and SimulationsHyewon Kim, Lanyan Fang, Jingyu Yu, et al.
The Journal of Pediatrics|June 1, 1988
Altered phenytoin clearance during intensive chemotherapy for acute lymphoblastic leukemiaP F Jarosinski, J A Moscow, M S Alexander, et al.
Pharmaceutical Research|December 2, 1998
The relative bioavailability and in vivo-in vitro correlations for four marketed carbamazepine tabletsM C Meyer, A B Straughn, R M Mhatre, et al.
Pharmaceutical Development and Technology|December 3, 1998
The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsulesD A Piscitelli, S Bigora, C Propst, et al.
Clinical Pharmacology and Therapeutics|December 5, 2000
Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceuticsM L Chen, S C Lee, M J Ng, et al.
Clinical and Translational Science|January 11, 2022
A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug developmentSarah Kim, Gezim Lahu, Majid Vakilynejad, et al.
Transplantation|October 1, 1988
Effects of allostimulation and cyclosporine therapy on cytotoxic antibody production in highly sensitized prospective renal transplant recipientsM R Weir, S Y Shen, F J Dagher, et al.
Pharmaceutical Research|August 4, 1998
Lack of in vivo/in vitro correlations for 50 mg and 250 mg primidone tabletsM C Meyer, A B Straughn, R M Mhatre, et al.
Pageof 24

Showing results (161-170 of 231) with videos related to

Sort By:
Pageof 24
Pharmacogenomics|July 21, 2021
Tabula Rasa HealthCare company profile: involvement in pharmacogenomic and personalized medicine researchAdriana Matos, Pamela Dow, Jennifer M Bingham, et al.
Clinical and Translational Science|February 22, 2022
Application of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitorsSarah Kim, Gezim Lahu, Majid Vakilynejad, et al.
Journal of Clinical Pharmacology|February 5, 2019
Is Bioequivalence Established Based on the Reference-Scaled Average Bioequivalence Approach Relevant to Chronic Administration of Phenytoin? Perspectives Based on Population Pharmacokinetic Modeling and SimulationsHyewon Kim, Lanyan Fang, Jingyu Yu, et al.
The Journal of Pediatrics|June 1, 1988
Altered phenytoin clearance during intensive chemotherapy for acute lymphoblastic leukemiaP F Jarosinski, J A Moscow, M S Alexander, et al.
Pharmaceutical Research|December 2, 1998
The relative bioavailability and in vivo-in vitro correlations for four marketed carbamazepine tabletsM C Meyer, A B Straughn, R M Mhatre, et al.
Pharmaceutical Development and Technology|December 3, 1998
The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsulesD A Piscitelli, S Bigora, C Propst, et al.
Clinical Pharmacology and Therapeutics|December 5, 2000
Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceuticsM L Chen, S C Lee, M J Ng, et al.
Clinical and Translational Science|January 11, 2022
A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug developmentSarah Kim, Gezim Lahu, Majid Vakilynejad, et al.
Transplantation|October 1, 1988
Effects of allostimulation and cyclosporine therapy on cytotoxic antibody production in highly sensitized prospective renal transplant recipientsM R Weir, S Y Shen, F J Dagher, et al.
Pharmaceutical Research|August 4, 1998
Lack of in vivo/in vitro correlations for 50 mg and 250 mg primidone tabletsM C Meyer, A B Straughn, R M Mhatre, et al.
Pageof 24